Applied Clinical Trials Online10h
Doravirine/Islatravir Regimen Shows Promise in Multiple Phase III Trials for the Treatment of HIV
The combination demonstrated non-inferiority to comparator antiretroviral therapies, meeting the primary efficacy success ...
GlobalData on MSN16h
MSD to push for approval of HIV combo after Phase III success
MSD’s HIV treatment is now back on track after an earlier hit which saw the FDA place a clinical hold on the therapy.
Le Lézard16h
ImmunityBio Announces First Dosing of Recombinant BCG (rBCG) in the U.S. and 60 Sites Are in the Process of Launching
ImmunityBio, Inc. , a leading immunotherapy company, today announced U.S. Urology Partners, one of the nation's largest independent providers of urology and related specialty services, is one of the ...
Bioengineered Protein Drugs Market Size to Cross USD 672.7 Billion by 2034, Growing at a CAGR of 6.2% - Report by Transparency Market Research, Inc.
The bioengineered protein drugs market is experiencing a paradigm shift, with pharmaceutical and biotech companies leveraging ...
FMIBlog22h
Salicylic Acid Market Poised for Significant Growth, Estimated to Reach USD 1,015.33 Million by 2035
The global salicylic acid market is projected to witness substantial growth, with its valuation anticipated to reach USD 1,015.33 million by 2035, growing at a CAGR of 7.1% from 2025 to 2035. This ...
FMIBlog20h
Global Electrophoresis Market Poised for Strong Growth, Expected to Reach USD 3,523.50 Million by 2033 at a CAGR of 4.5% | FMI
The global electrophoresis market is set to witness substantial growth, with its valuation projected to rise from USD 2,268.8 million in 2023 to USD 3,523.50 million by 2033. This expansion reflects a ...